BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20886808)

  • 1. Retinal involvement in patients with juvenile dermatomyositis.
    Brusco M; Hug D; Lasky A; Hoeltzel M
    J Pediatr Ophthalmol Strabismus; 2010 Sep; 47 Online():e1-4. PubMed ID: 20886808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycophenolate mofetil therapy for juvenile dermatomyositis with immune thrombocytopenic purpura.
    Ogimi C; Honma N; Tanaka R; Oh-ishi T
    Mod Rheumatol; 2012 Apr; 22(2):280-3. PubMed ID: 21710356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical features of patients with juvenile and adult dermatomyositis].
    Szalmás O; Nagy-Vince M; Dankó K; Farkas F
    Orv Hetil; 2015 Sep; 156(37):1491-6. PubMed ID: 26552025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
    Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
    Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Juvenile dermatomyositis with a rare and remarkable complication: sinus bradycardia.
    Karaca NE; Aksu G; Yeniay BS; Kutukculer N
    Rheumatol Int; 2006 Dec; 27(2):179-82. PubMed ID: 16944159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal interstitial pneumonia in juvenile dermatomyositis.
    Nagai Y; Mizuno T; Yoshizawa C; Ishikawa O
    Eur J Dermatol; 2010; 20(2):208-10. PubMed ID: 20110203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medications received by patients with juvenile dermatomyositis.
    Kishi T; Bayat N; Ward MM; Huber AM; Wu L; Mamyrova G; Targoff IN; Warren-Hicks WJ; Miller FW; Rider LG;
    Semin Arthritis Rheum; 2018 Dec; 48(3):513-522. PubMed ID: 29773230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Juvenile dermatomyositis: diagnosis and treatment].
    Gissinger-Prévot S; Figarella-Branger D; Mancini J; Chabrol B
    Arch Pediatr; 2008 Jan; 15(1):50-3. PubMed ID: 18164188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irreversible visual loss in dermatomyositis.
    Yeo LM; Swaby DS; Situnayake RD; Murray PI
    Br J Rheumatol; 1995 Dec; 34(12):1179-81. PubMed ID: 8608364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disease course, frequency of relapses and survival of patients with juvenile or adult dermatomyositis].
    Constantin T; Ponyi A; Kálovics T; Orbán I; Molnár K; Dérfalvy B; Dicso F; Sallai A; Garami M; Balogh Z; Szalai Z; Fekete G; Dankó K
    Orv Hetil; 2007 Oct; 148(42):1989-97. PubMed ID: 17932005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purtscher-Like Retinopathy in Hemolytic Uremic Syndrome.
    Stroh I; Nguyen A; Channa R
    JAMA Ophthalmol; 2019 Jan; 137(1):e183911. PubMed ID: 30629118
    [No Abstract]   [Full Text] [Related]  

  • 13. Retinal Manifestations of Juvenile Dermatomyositis: Case Report of Bilateral Diffuse Chorioretinopathy with Paracentral Acute Middle Maculopathy and Review of the Literature.
    Choi RY; Swan RJ; Hersh A; Vitale AT
    Ocul Immunol Inflamm; 2018; 26(6):929-933. PubMed ID: 28448730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-threatening systemic capillary leak syndrome in juvenile dermatomyositis.
    Meneghel A; Martini G; Birolo C; Tosoni A; Pettenazzo A; Zulian F
    Rheumatology (Oxford); 2017 Oct; 56(10):1822-1823. PubMed ID: 28957546
    [No Abstract]   [Full Text] [Related]  

  • 15. Atypical central retinal artery occlusion: an uncommon cause of retinopathy and visual loss in dermatomyositis.
    Sharma M; Prashar A; Tuli R; Sharma RK; Mahajan VK
    Int J Rheum Dis; 2019 Feb; 22(2):325-330. PubMed ID: 26403216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of intravenous Ig therapy in juvenile dermatomyositis.
    Lam CG; Manlhiot C; Pullenayegum EM; Feldman BM
    Ann Rheum Dis; 2011 Dec; 70(12):2089-94. PubMed ID: 21978999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and therapeutic challenges.
    Bowen BE; Manning RA; Foster JB; Kurup SK; Ramaiya KJ; Shah GK
    Retina; 2011 Oct; 31(9):1967-71. PubMed ID: 21866076
    [No Abstract]   [Full Text] [Related]  

  • 18. Diagnostic and therapeutic challenges.
    Pérez-Alvarez MJ; González-Guijarro J; Adán-Civera A; Moreno-López M; Williams DF; Nguyen QD
    Retina; 2007; 27(4):509-13. PubMed ID: 17420707
    [No Abstract]   [Full Text] [Related]  

  • 19. Dermatomyositis associated with generalized subcutaneous edema and Evans syndrome.
    Jung KD; Kim PS; Park HY; Kim CR; Byun JY; Lee DY; Lee JH; Yang JM; Lee ES
    J Am Acad Dermatol; 2012 Jan; 66(1):144-7. PubMed ID: 22030016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of intravenous immunoglobulin in the treatment of juvenile dermatomyositis: adverse reactions are associated with immunoglobulin A content.
    Manlhiot C; Tyrrell PN; Liang L; Atkinson AR; Lau W; Feldman BM
    Pediatrics; 2008 Mar; 121(3):e626-30. PubMed ID: 18299304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.